The federal Project Grant award for "PATHOGENESIS, DIAGNOSIS, AND TREATMENT OF CARDIOVASCULAR FAILURE IN ACUTE PANCREATITIS" was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The $1,665,000 award was made to Mayo Clinic Arizona, doing business as Mayo Clinic Hospital, on January 1, 2025 with a performance period ending December 31, 2028. Through this funding, Mayo Clinic Arizona will conduct research focused on understanding the pathogenesis, diagnosis, and treatment of cardiovascular complications associated with acute pancreatitis. As a sub-awardee, Mayo Collaborative Services, Inc. (Mayo Clinic Laboratories) will provide diagnostic testing and laboratory medicine services in support of the research program.
Generated 2/25/25, 2:45 AM